Paul Saladino· MD
I think that to me this would be a sea change because if it would think it would clearly clearly show who's at risk for coronary artery disease and it would shift the focus away from LDL
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think that to me this would be a sea change because if it would think it would clearly clearly show who's at risk for coronary artery disease and it would shift the focus away from LDL
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.